Drug Trial Radar · NCT03073967
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
158
Actual
Start
May 8, 2017
Primary completion
Aug 15, 2025
Study completion Nov 11, 2025
Sponsor
- Lead sponsor
- AiCuris Anti-infective Cures AGIndustry
- Sponsor type
- Industry
- Collaborators
- Medpace, Inc.
- First posted
- Mar 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or acyclovir susceptible mucocutaneous HSV infection, treated with pritelivir 100 mg once daily (following a loading dose of 400 mg as first dose to rapidly reach steady-state plasma concentration) or investigators choice, which can be either foscarnet 40 mg/kg every 8 hours or 60 mg/kg every 12 hours, or Cidofovir iv 5 mg/kg body weight given once weekly, or Cidofovir 1% or 3% topical applied 2 to 4 times daily, or Imiquimod 5% topical 3 times per week) (provided the drug is nationally approved).
Conditions
- HSV Infection
Interventions
PritelivirDrug
100 mg oral tablets
Investigator's choiceDrug
Foscarnet iv, 40 mg/kg BW tid or 60mg/kg bid or Cidofovir iv, 5 mg/kg BW given once weekly or Cidofovir 1% or 3%, topically applied 2 to 4 times daily or Imiquimod 5%, Solution for iv infusion or topical application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy measured by cure rateTime frame: Up to a maximum of 28 days
Locations
70 sites in 15 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Metro Infectious Disease Consultants, LLC - Huntsville
Huntsville, Alabama
University of South Alabama
Mobile, Alabama
University Arizona - Department of Medicine Arizona Health Sciences Center
Tucson, Arizona
City of Hope
Duarte, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California, Division of Infectious Diseases
Sacramento, California
Midland Florida Clinical Research Center, LLC
DeLand, Florida
Midway Immunology and Research Center (MIRC)
Ft. Pierce, Florida
University of Florida (UF) - Division of Infectious Disease
Gainesville, Florida
Links Clinical Trials
Miami, Florida
University of South Florida
Tampa, Florida
Emory Hospital Midtown Infectious Disease Clinic
Atlanta, Georgia
Metro Infectious Disease Consultants - Atlanta
Decatur, Georgia
Metro Infectious Disease Consultants, LLC
Burr Ridge, Illinois
Department of Medicine J. H. Stroger Hospital of Cook County
Chicago, Illinois
LSU Health Baton Rouge Pulmonary Clinic
Baton Rouge, Louisiana
Tulane University - School of Medicine
New Orleans, Louisiana
Johns Hopkins University School of Medicine
Baltimore, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
University of Minnesota
Minneapolis, Minnesota
Lee's Summit MO United States 64086
Lee's Summit, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Kings Country Hospital Center
Brooklyn, New York
David H. Koch Center at Memorial Sloan Kettering Cancer Center
New York, New York
Duke University Medical Center - Division of Infectious Diseases
Durham, North Carolina
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
MD Anderson Cancer Center
Houston, Texas
Fred Hutchinson Cancer Research Center
Seattle, Washington
Hospital Rawson
Córdoba, Argentina
Sanatorio Mayo Privado S.A.
Córdoba, Argentina
Instituto FIDES
La Plata, Argentina
Melbourne Health - Royal Melbourne Hospital
Parkville, Australia
Westmead Hospital, Centre for Infectious Disease and Microbiology
Westmead, Australia
AZ Sint-Jan Brugge
Bruges, Belgium
Centre Hospitalier Universitaire Saint Pierre
Brussels, Belgium
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.